235 related articles for article (PubMed ID: 34399818)
21. Bispecific antibodies and trispecific immunocytokines for targeting the immune system against cancer: preparing for the future.
Fournier P; Schirrmacher V
BioDrugs; 2013 Feb; 27(1):35-53. PubMed ID: 23329400
[TBL] [Abstract][Full Text] [Related]
22. CD33 directed bispecific antibodies in acute myeloid leukemia.
Clark MC; Stein A
Best Pract Res Clin Haematol; 2020 Dec; 33(4):101224. PubMed ID: 33279180
[TBL] [Abstract][Full Text] [Related]
23. T Cell Bispecific Antibodies: An Antibody-Based Delivery System for Inducing Antitumor Immunity.
Kamakura D; Asano R; Yasunaga M
Pharmaceuticals (Basel); 2021 Nov; 14(11):. PubMed ID: 34832954
[TBL] [Abstract][Full Text] [Related]
24. Bispecific Antibodies: A Smart Arsenal for Cancer Immunotherapies.
You G; Won J; Lee Y; Moon D; Park Y; Lee SH; Lee SW
Vaccines (Basel); 2021 Jul; 9(7):. PubMed ID: 34358141
[TBL] [Abstract][Full Text] [Related]
25. A novel tetravalent bispecific antibody targeting programmed death 1 and tyrosine-protein kinase Met for treatment of gastric cancer.
Hou W; Yuan Q; Yuan X; Wang Y; Mo W; Wang H; Yu M
Invest New Drugs; 2019 Oct; 37(5):876-889. PubMed ID: 30511201
[TBL] [Abstract][Full Text] [Related]
26. Bispecific Antibodies: From Research to Clinical Application.
Ma J; Mo Y; Tang M; Shen J; Qi Y; Zhao W; Huang Y; Xu Y; Qian C
Front Immunol; 2021; 12():626616. PubMed ID: 34025638
[TBL] [Abstract][Full Text] [Related]
27. Bispecific antibodies.
Kontermann RE; Brinkmann U
Drug Discov Today; 2015 Jul; 20(7):838-47. PubMed ID: 25728220
[TBL] [Abstract][Full Text] [Related]
28. Preconditioning of the tumor microenvironment with oncolytic reovirus converts CD3-bispecific antibody treatment into effective immunotherapy.
Groeneveldt C; Kinderman P; van den Wollenberg DJM; van den Oever RL; Middelburg J; Mustafa DAM; Hoeben RC; van der Burg SH; van Hall T; van Montfoort N
J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33082167
[TBL] [Abstract][Full Text] [Related]
29. Potential Role of CD47-Directed Bispecific Antibodies in Cancer Immunotherapy.
Yang Y; Yang Z; Yang Y
Front Immunol; 2021; 12():686031. PubMed ID: 34305918
[TBL] [Abstract][Full Text] [Related]
30. [Recent advances in the development of bispecific antibodies].
Ye J; Meng S; Zhu X
Sheng Wu Gong Cheng Xue Bao; 2020 Jan; 36(1):33-43. PubMed ID: 32072779
[TBL] [Abstract][Full Text] [Related]
31. Bispecific antibodies for the treatment of breast cancer.
Dillon PM; Tushir-Singh J; Lum LG
Expert Opin Biol Ther; 2022 Aug; 22(8):1017-1027. PubMed ID: 33896311
[TBL] [Abstract][Full Text] [Related]
32. Immunotherapeutic progress and application of bispecific antibody in cancer.
Kang J; Sun T; Zhang Y
Front Immunol; 2022; 13():1020003. PubMed ID: 36341333
[TBL] [Abstract][Full Text] [Related]
33. Bispecific antibodies: design, therapy, perspectives.
Sedykh SE; Prinz VV; Buneva VN; Nevinsky GA
Drug Des Devel Ther; 2018; 12():195-208. PubMed ID: 29403265
[TBL] [Abstract][Full Text] [Related]
34. Bispecific antibodies in haematological malignancies.
Viardot A; Bargou R
Cancer Treat Rev; 2018 Apr; 65():87-95. PubMed ID: 29635163
[TBL] [Abstract][Full Text] [Related]
35. BiSpec Pairwise AI: guiding the selection of bispecific antibody target combinations with pairwise learning and GPT augmentation.
Zhang X; Wang H; Sun C
J Cancer Res Clin Oncol; 2024 May; 150(5):237. PubMed ID: 38713378
[TBL] [Abstract][Full Text] [Related]
36. Bispecific Antibodies for Autoimmune and Inflammatory Diseases: Clinical Progress to Date.
Zhao Q
BioDrugs; 2020 Apr; 34(2):111-119. PubMed ID: 31916225
[TBL] [Abstract][Full Text] [Related]
37. Current status and future perspectives of bispecific antibodies in the treatment of lung cancer.
Wang W; Qiu T; Li F; Ren S
Chin Med J (Engl); 2023 Feb; 136(4):379-393. PubMed ID: 36848213
[TBL] [Abstract][Full Text] [Related]
38. Bispecific, T-Cell-Recruiting Antibodies in B-Cell Malignancies.
Lejeune M; Köse MC; Duray E; Einsele H; Beguin Y; Caers J
Front Immunol; 2020; 11():762. PubMed ID: 32457743
[TBL] [Abstract][Full Text] [Related]
39. Bispecific Antibody (bsAb) Construct Formats and their Application in Cancer Therapy.
Acheampong DO
Protein Pept Lett; 2019; 26(7):479-493. PubMed ID: 30864494
[TBL] [Abstract][Full Text] [Related]
40. Bispecific antibodies for cancer therapy: A review.
Krishnamurthy A; Jimeno A
Pharmacol Ther; 2018 May; 185():122-134. PubMed ID: 29269044
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
